A Randomised Trial on the Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy
Conditions: Breast Cancer Interventions: Other: manual treatment with osteopathic techniques and nutritional treatment; Other: manual treatment with osteopathic techniques; Other: nutritional treatment Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
Conditions: Cystic Fibrosis Interventions: Other: Mixed meal Sponsors: University of Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy
Conditions: Breast Cancer Interventions: Other: manual treatment with osteopathic techniques and nutritional treatment; Other: manual treatment with osteopathic techniques; Other: nutritional treatment Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Genentech ’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone
The inavolisib combination has the potential to address resistance to treatment and poor... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 8, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
Conditions: Polycystic Ovary Syndrome; Hormone Imbalance Interventions: Dietary Supplement: Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement Sponsors: Optify; Citruslabs Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Genentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Phase III (INAVO120) results shows that inavolisib in combination with palbociclib and fulvestrant significantly improved progression-free survival in the first-line setting
PIK3CA mutations, found in approximately 40% of HR-positive... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 4, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Conditions: Prostatic Neoplasms Interventions: Drug: Novel hormonal therapy Sponsors: Pfizer; Astellas Pharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Changes in the Hormonal and Inflammatory Profile of Young Sprint- and Endurance-trained Athletes.
Conditions: Overtraining, Exercise Interventions: Other: Exercise training Sponsors: Poznan University of Physical Education Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Attitudes and barriers to participation in window-of-opportunity trials reported by White and Asian/Asian British ethnicity patients who have undergone treatment for endometrial cancer
This study provides important insights into patients ’ views on WOT participation in EC and raises issues that need to be considered for future trial design and participant recruitment materials. The timing and format of study information and type of substance under investigation were factors influencing potential participation. Future studies shoul d consider using multi-lingual visual information videos to address information needs, as this may encourage participation by ethnic minority patients. (Source: Trials)
Source: Trials - November 25, 2023 Category: Research Source Type: clinical trials
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Conditions: Endometriosis Ovary Interventions: Drug: Dienogest; Drug: Depo Medroxyprogesterone acetate; Drug: Leuprolide (as Leuprolide Acetate); Drug: Levonogestrel + etinilestradiol (30 mcg, brand name Mycrogynon) Sponsors: Universitas Diponegoro Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study
Conditions: Prostate Cancer Interventions: Drug: Luteinising Hormone-Releasing Factor Analogue Sponsors: University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer
Conditions: Breast Cancer Invasive; Hormone-receptor-positive Breast Cancer; HER2 Low Breast Carcinoma; Early-stage Breast Cancer Interventions: Drug: Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel; Drug: Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Effects of Sex Hormones and Alcohol on Sleep
Conditions: Alcohol Use Disorder Interventions: Drug: Ethanol; Drug: Saline Sponsors: Lauren Whitehurst; Ohio State University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.
Conditions: Patients With Metastatic Castration-resistant Prostate Cancer Interventions: Radiation: 177Lu-PSMA-617 PET scan Sponsors: Centre Georges Francois Leclerc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study of MK-5684 Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC); Prostatic Neoplasms Interventions: Drug: MK-5684; Drug: Dexamethasone; Drug: Fludrocortisone acetate; Drug: Hydrocortisone; Drug: Abiraterone acetate; Drug: Prednisone acetate; Drug: Enzalutamide Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
